Multitarget disease-modifying therapy in Parkinson's disease?

被引：13
|
作者：
Calabresi, Paolo [1 ,2 ]
Di Filippo, Massimiliano [1 ]
机构：
[1] Univ Perugia, Osped Santa Maria Misericordia, Neurol Clin, Dept Med, I-06156 Perugia, Italy
[2] IRCCS Fdn Santa Lucia, Rome, Italy
来源：
LANCET NEUROLOGY | 2015年 / 14卷 / 10期
关键词：
D O I：
10.1016/S1474-4422(15)00227-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：975 / 976
页数：3
相关论文
共 50 条
  • [1] Mechanism of Mesenchymal Stem Cells as a Multitarget Disease-Modifying Therapy for Parkinson's Disease
    Unnisa, Aziz
    Dua, Kamal
    Kamal, Mohammad Amjad
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (04) : 988 - 1000
  • [2] Immunotherapy for Parkinson's Disease and Alzheimer's Disease: A Promising Disease-Modifying Therapy
    Mahboob, Anns
    Ali, Hasan
    Alnaimi, Aljazi
    Yousef, Mahmoud
    Rob, Mlaak
    Al-Muhannadi, Nawaf Ahmad
    Senevirathne, Degiri Kalana Lasanga
    Chaari, Ali
    CELLS, 2024, 13 (18)
  • [3] α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease
    Cole, Tracy A.
    Zhao, Hien
    Collier, Timothy J.
    Sandoval, Ivette
    Sortwell, Caryl E.
    Steece-Collier, Kathy
    Daley, Brian F.
    Booms, Alix
    Lipton, Jack
    Welch, Mackenzie
    Berman, Melissa
    Jandreski, Luke
    Graham, Danielle
    Weihofen, Andreas
    Celano, Stephanie
    Schulz, Emily
    Cole-Strauss, Allyson
    Luna, Esteban
    Quach, Duc
    Mohan, Apoorva
    Bennett, C. Frank
    Swayze, Eric E.
    Kordasiewicz, Holly B.
    Luk, Kelvin C.
    Paumier, Katrina L.
    JCI INSIGHT, 2021, 6 (05)
  • [4] Disease-Modifying Drugs in Parkinson’s Disease
    Ariane Park
    Mark Stacy
    Drugs, 2015, 75 : 2065 - 2071
  • [5] Disease-modifying drugs and Parkinson's disease
    Allain, Herve
    Bentue-Ferrer, Daniele
    Akwa, Yvette
    PROGRESS IN NEUROBIOLOGY, 2008, 84 (01) : 25 - 39
  • [6] Disease-Modifying Drugs in Parkinson's Disease
    Park, Ariane
    Stacy, Mark
    DRUGS, 2015, 75 (18) : 2065 - 2071
  • [7] Disease-Modifying Strategies for Parkinson's Disease
    Kalia, Lorraine V.
    Kalia, Suneil K.
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2015, 30 (11) : 1442 - 1450
  • [8] Mitochondrial therapy for Parkinson's disease: Neuroprotective pharmaconutrition may be disease-modifying
    Kones, Richard
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2010, 2 : 185 - 198
  • [9] Promising disease-modifying therapies for Parkinson's disease
    Dawson, Valina L.
    Dawson, Ted M.
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (520)
  • [10] Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
    Yi Zhuo
    Xuan Li
    Zhengwen He
    Ming Lu
    Stem Cell Research & Therapy, 14
12345